Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,597,000 | 1,248,100 | 4,328,800 | 3,413,400 | 2,471,600 |
| Depreciation Amortization | 645,000 | 299,400 | 1,297,800 | 922,000 | 612,300 |
| Income taxes - deferred | 317,200 | 230,500 | 189,900 | 306,300 | 340,100 |
| Accounts receivable | N/A | N/A | -492,900 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | -200,100 | N/A | N/A |
| Other Working Capital | -703,500 | -815,100 | -956,900 | -1,768,000 | -1,194,900 |
| Other Operating Activity | 13,900 | -4,900 | 168,900 | -556,800 | -1,217,900 |
| Operating Cash Flow | $2,869,600 | $958,000 | $4,335,500 | $2,316,900 | $1,011,200 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,600 | -800 | 399,100 | 563,200 | 457,800 |
| PPE Investments | -279,300 | -125,100 | -747,300 | -508,200 | -333,900 |
| Net Acquisitions | -148,400 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -252,200 | -57,200 | -432,300 | -329,300 | -122,800 |
| Sale Of Investment | 383,000 | 191,000 | 1,107,800 | 742,200 | 367,400 |
| Purchase Sale Intangibles | -400,000 | 0 | N/A | N/A | N/A |
| Other Investing Activity | -507,300 | -60,500 | -184,500 | -70,800 | -39,100 |
| Investing Cash Flow | $-806,800 | $-52,600 | $142,800 | $397,100 | $329,400 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,300 | -7,900 | -5,824,200 | -4,829,400 | -4,812,800 |
| Debt Issued | 700 | 0 | 2,400,000 | 2,000,000 | 2,400,000 |
| Dividend Paid | -1,075,900 | -539,200 | -2,152,100 | -1,612,400 | -1,075,800 |
| Other Financing Activity | -2,000 | 100 | 42,600 | 36,600 | -3,400 |
| Financing Cash Flow | $-1,078,500 | $-547,000 | $-5,533,700 | $-4,405,200 | $-3,492,000 |
| Exchange Rate Effect | -283,700 | -96,100 | 21,600 | 42,700 | -23,000 |
| Beginning Cash Position | 4,462,900 | 4,462,900 | 5,496,700 | 5,496,700 | 5,496,700 |
| End Cash Position | 5,163,500 | 4,725,200 | 4,462,900 | 3,848,200 | 3,322,300 |
| Net Cash Flow | $700,600 | $262,300 | $-1,033,800 | $-1,648,500 | $-2,174,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,869,600 | 958,000 | 4,335,500 | 2,316,900 | 1,011,200 |
| Capital Expenditure | -279,300 | -125,100 | -765,000 | -508,200 | -333,900 |
| Free Cash Flow | 2,590,300 | 832,900 | 3,570,500 | 1,808,700 | 677,300 |